181 related articles for article (PubMed ID: 25727243)
1. Reversibility after inhaling salbutamol in different body postures in asthmatic children: a pilot study.
Visser R; van der Palen J; de Jongh FH; Thio BJ
Respir Med; 2015 Apr; 109(4):459-62. PubMed ID: 25727243
[TBL] [Abstract][Full Text] [Related]
2. Reversibility of pulmonary function after inhaling salbutamol in different doses and body postures in asthmatic children.
Visser R; Kelderman S; de Jongh FH; van der Palen J; Thio BJ
Respir Med; 2015 Oct; 109(10):1274-9. PubMed ID: 26341548
[TBL] [Abstract][Full Text] [Related]
3. The effect of body posture during medication inhalation on exercise induced bronchoconstriction in asthmatic children.
Visser R; Wind M; de Graaf BJ; de Jongh FH; van der Palen J; Thio BJ
Respir Med; 2015 Oct; 109(10):1257-61. PubMed ID: 26341547
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Priming new Plastic Spacers with 20 Puffs Salbutamol on Bronchodilator Response in Asthmatic Children.
Sadri H; Fazlollahi MR
Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):231-234. PubMed ID: 38822517
[TBL] [Abstract][Full Text] [Related]
6. [Association between body mass index and lung function in children with asthma after corticosteroids inhalation].
Ye ZH; Huang Y; Wang Y; Wang DJ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):983-6. PubMed ID: 24229594
[TBL] [Abstract][Full Text] [Related]
7. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
Lötvall J; Ankerst J
Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
[TBL] [Abstract][Full Text] [Related]
8. Heliox and forward-leaning posture improve the efficacy of nebulized bronchodilator in acute asthma: a randomized trial.
Brandão DC; Britto MC; Pessoa MF; de Sá RB; Alcoforado L; Matos LO; Silva TN; de Andrade AD
Respir Care; 2011 Jul; 56(7):947-52. PubMed ID: 21352660
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhaled MgSO4 on FEV1 and PEF in children with asthma induced by acetylcholine: a randomized controlled clinical trail of 330 cases.
Sun YX; Gong CH; Liu S; Yuan XP; Yin LJ; Yan L; Shi TT; Dai JH
J Trop Pediatr; 2014 Apr; 60(2):141-7. PubMed ID: 24343824
[TBL] [Abstract][Full Text] [Related]
10. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
[TBL] [Abstract][Full Text] [Related]
11. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
Koch S; Ahn JR; Koehle MS
Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
[TBL] [Abstract][Full Text] [Related]
12. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
13. Second-order Texture Measurements of (3)He Ventilation MRI: Proof-of-concept Evaluation of Asthma Bronchodilator Response.
Zha N; Pike D; Svenningsen S; Capaldi DP; McCormack DG; Parraga G
Acad Radiol; 2016 Feb; 23(2):176-85. PubMed ID: 26601971
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
Völkl KP; Kroll VM; Wiesemann HG; Schneider B
Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
[TBL] [Abstract][Full Text] [Related]
15. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma.
Kishida M; Suzuki I; Kabayama H; Koshibu T; Izawa M; Takeshita Y; Kurita F; Okada M; Shinomiya N; Aoki T
J Asthma; 2002 Jun; 39(4):337-9. PubMed ID: 12095184
[TBL] [Abstract][Full Text] [Related]
16. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols.
Usmani OS; Biddiscombe MF; Nightingale JA; Underwood SR; Barnes PJ
J Appl Physiol (1985); 2003 Nov; 95(5):2106-12. PubMed ID: 12897033
[TBL] [Abstract][Full Text] [Related]
17. Salbutamol in the treatment of asthmatic children. A comparison of oral and inhalation therapy alone and in combination.
Berg IM; Berg T; Ringqvist I
Eur J Respir Dis; 1982 Jul; 63(4):305-9. PubMed ID: 7117428
[TBL] [Abstract][Full Text] [Related]
18. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
20. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma.
Louridas G; Kakoura M; Galanis N; Patakas D; Kastritsi K
Respiration; 1983; 44(6):439-43. PubMed ID: 6648053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]